Albert Jang
Medical Oncology · Rochester, MNNPI 1003376468
Payments from drug & device makers
Across 135 payments — averaging $48.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$657
- Merck$545
- Pfizer$499
- Takeda Pharmaceuticals U.S.A., Inc.$469
- Dendreon Pharmaceuticals LLC$339
- Johnson & Johnson$338
- plus $4K from 32 others
What the payments were for
- Food & beverage$6,31596%
- Education$2934%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 13 | $657 |
| Merck | 12 | $545 |
| Pfizer | 10 | $499 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $469 |
| Dendreon Pharmaceuticals LLC | 3 | $339 |
| Johnson & Johnson | 3 | $338 |
| E.r. Squibb & Sons, L.L.C. | 5 | $331 |
| Beone Medicines USA, Inc. | 3 | $296 |
| Gilead(2 entities) | 4 | $283 |
| Seagen Inc. | 3 | $252 |
| Daiichi Sankyo Inc. | 5 | $230 |
| Novartis | 10 | $217 |
| Incyte Corporation | 5 | $169 |
| Eisai Inc. | 6 | $165 |
| Jazz Pharmaceuticals Inc. | 2 | $147 |
| Exelixis Inc. | 1 | $134 |
| Amgen | 1 | $129 |
| Beigene USA, Inc. | 1 | $125 |
| Bayer | 1 | $118 |
| EMD Serono, Inc. | 1 | $115 |
| Sanofi | 5 | $114 |
| Foundation Medicine, Inc. | 2 | $106 |
| GSK | 1 | $89 |
| AbbVie | 4 | $89 |
| Bristol Myers Squibb | 4 | $70 |
| AVEO Pharmaceuticals, Inc. | 3 | $70 |
| Tempus AI, Inc | 1 | $70 |
| Medexus Pharma, Inc. | 1 | $61 |
| GT Medical Technologies, Inc | 1 | $61 |
| Genmab U.S., Inc. | 3 | $59 |
| Astellas Pharma US Inc | 2 | $56 |
| Blueprint Medicines Corporation | 2 | $51 |
| Sobi, Inc | 2 | $42 |
| Morphosys, US Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $27 |
| Agios Pharmaceuticals, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $15 |
| Verity Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,608 in reported general payments places this provider in the 35th percentile of 133 medical oncology providers in Minnesota.
Other medical oncology in Rochester
- Evanthia GalanisRochester$72.3M
- Frank SinicropeRochester$10.3M
- Harry YoonRochester$10.2M
- Konstantinos LeventakosRochester$9.6M
- Matthew BlockRochester$8.1M
- Keith BibleRochester$7.5M
- Jian CampianRochester$7.3M
- Katharine PriceRochester$7M
- Robert McWilliamsRochester$6.3M
- Elisabeth HeathRochester$6.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.